There has recently been interest in the role of inverse bremsstrahlung, the emission of photons by fast suprathermal ions in collisions with ambient electrons possessing relatively low velocities, in tenuous plasmas in various astrophysical contexts. This follows a long hiatus in the application of suprathermal ion bremsstrahlung to astrophysical models since the early 1970s. The potential impo...

Quantitative Yttrium-90 ((90)Y) bremsstrahlung single photon emission computed tomography (SPECT) imaging has shown great potential to provide reliable estimates of (90)Y activity distribution for targeted radionuclide therapy dosimetry applications. One factor that potentially affects the reliability of the activity estimates is the choice of the acquisition energy window. In contrast to imagi...

Quantitative imaging of bremsstrahlung from pure beta emitters is proposed as a means for in vivo management of antibody therapy. The method involves the use of high-energy collimation, an empirically selected broad photon energy window to enhance detector sensitivity, and a Wiener restoration filter to compensate for system blur. The measured and filtered data were obtained for an idealized sc...

Bremsstrahlung is one of the basic photon-matter processes occurring in collisions of electrons with atoms and ions. Bremsstrahlung in electron-atom collisions has been the object of extensive experimental and theoretical studies [1]. These studies focused on the angular dependence of the intensity distribution of the bremsstrahlung, as well as on its linear polarization [2]. Another production...

We present the Suzaku results of η Carinae in the 5–50 keV range conducted twice around the apastron in 2005 August for 50 ks and in 2006 February for 20 ks. The X-ray Imaging Spectrometer (XIS) produced hard (5–12 keV) band spectra, resolving K shell lines from highly ionized Fe and Ni. The Hard X-ray Detector yielded a significant detection in the super-hard (15–50 keV) band, which is unconta...

Radiomicrosphere treatment involves the intrahepatic arterial administration of (90)Y-resin or (90)Y-glass microspheres. The microspheres are biocompatible, but not biodegradable, and little to no (90)Y leaches from the microspheres. Without any bioelimination, the beta-dose delivery is generally confined to the liver. Although U.S. Nuclear Regulatory Commission requirements permit patients tre...